Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
HDFC Pharma and Healthcare Fund vs Motilal Oswal BSE Healthcare ETF
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
35 companies both funds hold · largest common part first
Only in A
3 companies · largest first
Only in B
102 companies · largest first
- Laurus Labs Limited4.84%
- Aurobindo Pharma Limited2.90%
- Fortis Healthcare Limited2.52%
- Mankind Pharma Limited1.75%
- Ajanta Pharma Limited1.02%
- Dr. Lal Path Labs Ltd.0.96%
- Abbott India Limited0.87%
- Piramal Pharma Limited0.81%
- Narayana Hrudayalaya Ltd.0.78%
- Granules India Limited0.76%
- Onesource Specialty Pharma Limited0.75%
- GlaxoSmithKline Pharmaceuticals Limited0.71%
- Emcure Pharmaceuticals Limited0.51%
- Strides Pharma Science Limited0.47%
- Natco Pharma Limited0.47%
And 87 more.
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 91.2% | 94.1% | -2.96 pp |
| Consumer Services | 1.0% | 0.0% | +1.04 pp |
| Not classified | 7.8% | 5.9% | +1.91 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →